TN2013000187A1 - Pharmaceutical composition, methods for treating and uses thereof - Google Patents
Pharmaceutical composition, methods for treating and uses thereofInfo
- Publication number
- TN2013000187A1 TN2013000187A1 TNP2013000187A TN2013000187A TN2013000187A1 TN 2013000187 A1 TN2013000187 A1 TN 2013000187A1 TN P2013000187 A TNP2013000187 A TN P2013000187A TN 2013000187 A TN2013000187 A TN 2013000187A TN 2013000187 A1 TN2013000187 A1 TN 2013000187A1
- Authority
- TN
- Tunisia
- Prior art keywords
- treating
- methods
- pharmaceutical composition
- type
- diabetes mellitus
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
- 208000002705 Glucose Intolerance Diseases 0.000 abstract 1
- 102000004877 Insulin Human genes 0.000 abstract 1
- 108090001061 Insulin Proteins 0.000 abstract 1
- 229940123518 Sodium/glucose cotransporter 2 inhibitor Drugs 0.000 abstract 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 abstract 1
- 201000001421 hyperglycemia Diseases 0.000 abstract 1
- 229940125396 insulin Drugs 0.000 abstract 1
- 208000030159 metabolic disease Diseases 0.000 abstract 1
- 201000009104 prediabetes syndrome Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention relates to a pharmaceutical composition according to the claim 1 comprising an SGLT2 inhibitor and an insulin which is suitable in the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2011/069532 WO2012062698A1 (en) | 2010-11-08 | 2011-11-07 | Pharmaceutical composition, methods for treating and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TN2013000187A1 true TN2013000187A1 (en) | 2014-11-10 |
Family
ID=54360619
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNP2013000187A TN2013000187A1 (en) | 2011-11-07 | 2013-04-29 | Pharmaceutical composition, methods for treating and uses thereof |
Country Status (1)
| Country | Link |
|---|---|
| TN (1) | TN2013000187A1 (en) |
-
2013
- 2013-04-29 TN TNP2013000187A patent/TN2013000187A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12018500767A1 (en) | Pharmaceutical composition, methods for treating and uses thereof | |
| PH12013500808A1 (en) | Pharmaceutical combinations for the treatment of metabolic disorders | |
| PH12016501607B1 (en) | Sglt-2 inhibitor for treating type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance or hyperglycemia | |
| TN2011000415A1 (en) | Pharmaceutical composition comprising a sglt2 inhibitor a dpp-i v inhibitor and optionally a further antidiabetic agent and uses thereof | |
| PH12020500352A1 (en) | Therapeutic uses of empagliflozin | |
| UA100384C2 (en) | Pharmaceutical composition comprising a glucopyranosyl-substituted benzene derivative | |
| MX2010001560A (en) | Pharmaceutical composition comprising a sglt2 inhibitor in combination with a dpp-iv inhibitor. | |
| EA201101187A1 (en) | ANTI-DIABETIC MEDICINES CONTAINING DPP-4 INHIBITOR (LINAGLIPTIN) OPTIONAL IN COMBINATION WITH OTHER ANTI-DIABETIC MEANS | |
| EP2217596B8 (en) | Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119 | |
| MX378422B (en) | Therapeutic uses of empagliflozin | |
| WO2010029089A3 (en) | Combination therapy for the treatment of diabetes and related conditions | |
| EP4327867A3 (en) | Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient | |
| PH12014500075A1 (en) | Pharmaceutical composition, methods for treating and uses thereof | |
| PH12014502448A1 (en) | Pharmaceutical combinations for the treatment of metabolic disorders | |
| MX2012006734A (en) | Ppar-sparing thiazolidinediones and combinations for the treatment of obesity and other metabolic diseases. | |
| TN2013000187A1 (en) | Pharmaceutical composition, methods for treating and uses thereof | |
| WO2014014816A3 (en) | Methods of treating glucose metabolism disorders |